PubRank

Ramon Brugada

Author PubWeight™ 144.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 8.76
2 An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2009 4.99
3 HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011 4.31
4 HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011 2.54
5 Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005 2.48
6 Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 2003 2.44
7 Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005 2.39
8 Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007 2.33
9 De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005 2.27
10 Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol 2012 2.26
11 Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002 2.16
12 Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol 2011 2.14
13 Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2006 2.11
14 Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005 1.94
15 Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003 1.92
16 Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm 2006 1.91
17 Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002 1.91
18 Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 2004 1.87
19 Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol 2004 1.81
20 Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008 1.81
21 Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 2005 1.74
22 Electrophysiologic testing predicts events in Brugada syndrome patients. Heart Rhythm 2011 1.70
23 Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol 2004 1.69
24 Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008 1.67
25 State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol 2011 1.61
26 Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm 2006 1.56
27 Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 2003 1.54
28 Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol 2007 1.52
29 Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res 2011 1.51
30 The cloning, genomic organization and tissue expression profile of the human DLG5 gene. BMC Genomics 2002 1.50
31 Fever and Brugada syndrome. Pacing Clin Electrophysiol 2002 1.48
32 Shocking truths about implantable cardioverter defibrillator monitoring zones. Pacing Clin Electrophysiol 2007 1.48
33 Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013 1.47
34 Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol 2011 1.47
35 KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm 2009 1.43
36 Rebuttal to EP testing does not predict cardiac events in patients with Brugada syndrome. Heart Rhythm 2011 1.39
37 Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 2009 1.28
38 Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004 1.14
39 Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel. Heart 2011 1.12
40 Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol 2009 1.11
41 Brugada syndrome unmasked by pneumonia. Tex Heart Inst J 2006 1.10
42 Genetic modulation of brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol 2009 1.09
43 Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation 2006 1.08
44 Brugada syndrome: from cell to bedside. Curr Probl Cardiol 2005 1.08
45 Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation. Epilepsy Res 2013 1.04
46 Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm 2007 1.04
47 Brugada syndrome. Prog Cardiovasc Dis 2008 1.03
48 Brugada syndrome: update 2009. Hellenic J Cardiol 2009 1.03
49 Genetics and cardiac channelopathies. Genet Med 2010 1.00
50 Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Circ Res 2008 1.00
51 Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents. Atherosclerosis 2011 1.00
52 Atrial fibrillation: evidence for genetically determined disease. Curr Opin Cardiol 2008 0.99
53 Analysis of mRNA from human heart tissue and putative applications in forensic molecular pathology. Forensic Sci Int 2010 0.98
54 Genetics and arrhythmias. Annu Rev Med 2002 0.94
55 Novel mutations in domain I of SCN5A cause Brugada syndrome. Mol Genet Metab 2002 0.94
56 Negative autopsy and sudden cardiac death. Int J Legal Med 2014 0.93
57 A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Heart Rhythm 2008 0.92
58 The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis. J Mol Cell Cardiol 2008 0.91
59 Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome. J Cardiovasc Electrophysiol 2008 0.90
60 Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm 2008 0.89
61 Genetics of Brugada syndrome. Curr Opin Cardiol 2010 0.89
62 The cardiac sodium channel is post-translationally modified by arginine methylation. J Proteome Res 2011 0.89
63 A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome. Hum Mutat 2013 0.88
64 Validation of warfarin pharmacogenetic algorithms in clinical practice. Pharmacogenomics 2012 0.88
65 Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised. Eur Heart J 2010 0.87
66 Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia 2013 0.87
67 Genetics of arrhythmogenic right ventricular cardiomyopathy. J Med Genet 2013 0.87
68 Channelopathies: a new category of diseases causing sudden death. Herz 2007 0.87
69 Heart rate variability analysis indicates preictal parasympathetic overdrive preceding seizure-induced cardiac dysrhythmias leading to sudden unexpected death in a patient with epilepsy. Epilepsia 2014 0.87
70 Mild Beckwith-Wiedemann and severe long-QT syndrome due to deletion of the imprinting center 2 on chromosome 11p. Eur J Hum Genet 2013 0.86
71 Increase in sudden death from coronary artery disease in young adults. Am Heart J 2011 0.85
72 Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci Int 2012 0.85
73 The Brugada ECG pattern in a neonate. J Cardiovasc Electrophysiol 2005 0.85
74 Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol 2014 0.85
75 Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series. Int J Legal Med 2014 0.85
76 Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation. Heart Rhythm 2010 0.84
77 Arrhythmia and right heart disease: from genetic basis to clinical practice. Rev Esp Cardiol 2010 0.84
78 Genetic basis of ventricular arrhythmias. Cardiol Clin 2008 0.84
79 Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel. FEBS Lett 2013 0.83
80 Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm. J Interv Card Electrophysiol 2008 0.82
81 DiBAC₄(3) hits a "sweet spot" for the activation of arterial large-conductance Ca²⁺-activated potassium channels independently of the β₁-subunit. Am J Physiol Heart Circ Physiol 2013 0.81
82 Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation. J Clin Pathol 2012 0.81
83 Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 2007 0.80
84 A Genetically Vulnerable Myocardium May Predispose to Myocarditis. J Am Coll Cardiol 2015 0.79
85 A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome. PLoS One 2013 0.79
86 Molecular heterogeneity of large-conductance calcium-activated potassium channels in canine intracardiac ganglia. Channels (Austin) 2013 0.79
87 Genetics of familial atrial fibrillation. Europace 2009 0.79
88 Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome. J Cardiovasc Med (Hagerstown) 2007 0.79
89 Brugada syndrome: diagnostic pitfalls. J Emerg Med 2009 0.78
90 Nestin (+) stem cells independently contribute to neural remodelling of the ischemic heart. J Cell Physiol 2011 0.78
91 Conduction abnormalities in the right ventricular outflow tract in Brugada syndrome detected body surface potential mapping. Conf Proc IEEE Eng Med Biol Soc 2010 0.78
92 The cloning, genomic organization and tissue expression profile of the human DLG5 gene: Correction. BMC Genomics 2002 0.78
93 Genetics of sudden cardiac death in children and young athletes. Cardiol Young 2012 0.78
94 Cardiovascular translational medicine (IV): The genetic basis of malignant arrhythmias and cardiomyopathies. Rev Esp Cardiol 2009 0.78
95 Brugada syndrome and p.E61X_RANGRF. Cardiol J 2013 0.78
96 Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index. Atherosclerosis 2010 0.78
97 The phenotype and potential origin of nestin+ cardiac myocyte-like cells following infarction. J Appl Physiol (1985) 2009 0.78
98 Analysis of the arrhythmogenic substrate in human heart failure. Cardiovasc Pathol 2012 0.77
99 Brugada syndrome with marked conduction disease: dual implications of a SCN5A mutation. Pacing Clin Electrophysiol 2008 0.77
100 Kir2.3 knock-down decreases IK1 current in neonatal rat cardiomyocytes. FEBS Lett 2008 0.77
101 T-Wave morphology in short QT syndrome. Ann Noninvasive Electrocardiol 2009 0.77
102 Interplay between R513 methylation and S516 phosphorylation of the cardiac voltage-gated sodium channel. Amino Acids 2014 0.77
103 Genetic basis of ventricular arrhythmias. Heart Fail Clin 2010 0.77
104 Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation. Eur J Hum Genet 2012 0.77
105 Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments. Am Heart J 2011 0.77
106 Characteristics of inverse-computed epicardial electrograms of Brugada syndrome patients. Conf Proc IEEE Eng Med Biol Soc 2011 0.76
107 Cardiac arrest and left ventricular fibrosis in a Finnish family with the lamin A/C mutation. J Cardiovasc Electrophysiol 2007 0.76
108 Role of novel DSP_p.Q986X genetic variation in arrhythmogenic right ventricular cardiomyopathy. Eur J Med Genet 2013 0.76
109 Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation? Cardiology 2007 0.76
110 When our best is not enough: the death of a teenager with Brugada syndrome. J Cardiovasc Electrophysiol 2008 0.76
111 SCN5A mutation associated with acute myocardial infarction. Leg Med (Tokyo) 2009 0.76
112 Short QT syndrome: Should we push the frontier forward? Heart Rhythm 2005 0.76
113 Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects. Int J Legal Med 2014 0.76
114 Subcellular localisation of retromer in post-endocytic pathways of polarised Madin-Darby canine kidney cells. Biol Cell 2014 0.76
115 Genetic causes of sudden infant death syndrome: a postmortem investigation not to be missed. Am J Forensic Med Pathol 2013 0.75
116 A nonsense SCN5A mutation associated with Brugada-type electrocardiogram and intraventricular conduction defects. Pacing Clin Electrophysiol 2009 0.75
117 Correction: Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation. PLoS One 2017 0.75
118 Genetics, ethics and ethnicity. Heart Rhythm 2004 0.75
119 The Brugada syndrome. Card Electrophysiol Rev 2002 0.75
120 Genetics of inherited arrhythmias in pediatrics. Curr Opin Pediatr 2015 0.75
121 Brugada syndrome. Indian Heart J 2012 0.75
122 The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. Cardiovasc Drugs Ther 2002 0.75
123 Update about atrial fibrillation genetics. Curr Opin Cardiol 2017 0.75
124 Erratum to: Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects. Int J Legal Med 2015 0.75
125 Molecular autopsy of sudden cardiac death (SCD): the challenge of forensic pathologist to the complexity of genomics. Am J Forensic Med Pathol 2005 0.75
126 Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome. Circ J 2015 0.75
127 [Same genotype and different phenotypes in a family with PRKAG2 gene mutation]. Zhonghua Xin Xue Guan Bing Za Zhi 2007 0.75
128 High sensitivity of the sheep pulmonary vein antrum to acetylcholine stimulation. J Appl Physiol (1985) 2008 0.75
129 Brugada syndrome: 12 years of progression. Acta Med Okayama 2004 0.75